Arcadia Biosciences (RKDA) Profit After Tax (2014 - 2026)

Arcadia Biosciences (RKDA) has 12 years of Profit After Tax data on file, last reported at -$1.3 million in Q4 2025.

• Quarterly Profit After Tax rose 66.91% year-over-year to -$1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.3 million (up 59.62% YoY) and the FY2025 annual result came in at -$2.3 million, up 45.82% from the prior year.
• Profit After Tax fell to -$1.3 million in Q4 2025, from $856000.0 in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $144.0 million in Q2 2021 to a low of -$9.4 million in Q1 2023.
• A 5-year average of $5.4 million and a median of -$2.3 million in 2021 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2021 — Profit After Tax jumped 1555.57% — and 2022, when it tumbled 374.24%.
• Tracing RKDA's Profit After Tax over 5 years: stood at -$7.5 million in 2021, then jumped by 43.41% to -$4.2 million in 2022, then surged by 236.76% to $5.8 million in 2023, then sank by 169.56% to -$4.0 million in 2024, then jumped by 66.91% to -$1.3 million in 2025.
• The last three Profit After Tax figures came in at -$1.3 million (Q4 2025), $856000.0 (Q3 2025), and -$4.5 million (Q2 2025), per Business Quant data.